Breakage and Elution of CSTD by Oil-based Solvents in Injection Drugs
-
Published:2021-10-10
Issue:10
Volume:47
Page:590-596
-
ISSN:1346-342X
-
Container-title:Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
-
language:en
-
Short-container-title:Jpn. J. Pharm. Health Care Sci.
Author:
Haruta Kyohei1, Aoi Hiroshi1, Kimura Kinuko1, Okada Kazuya1, Mikami Chika1, Murata Masaki1, Matsuda Sayo1, Sado Kana1, Yoshikawa Ichigo1, Ikeda Kazuyuki1
Affiliation:
1. Department of Pharmacy, Nara Medical University Hospital
Publisher
Japanese Society of Pharmaceutical Health Care and Sciences
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference13 articles.
1. 1）平成26年5月29日, 基安化発0529第2号, 発がん性等を有する化学物質を含有する抗がん剤等に対するばく露防止対策について（厚生労働省労働基準局安全衛生部化学物質対策課長）． 2. 2）日本がん看護学会, 日本臨床腫瘍学会, 日本臨床腫瘍薬学会編, “がん薬物療法における曝露対策ガイドライン”, 2019年度版, 金原出版, 東京, 2019, pp53-55, pp78-80. 3. 3）Grochow LB, Busulfan disposition: the role of therapeutic monitoring in bone marrow transplantation induction regimens, Semin Oncol, 1993, 20, 18-25. 4. 4）Slattery JT, Clift RA, Buckner CD, Radich J, Storer B, Bensinger WI, Soll E, Anasetti C, Bowden R, Bryant E, Chauncey T, Deeg HJ, Doney KC, Flowers M, Gooley T, Hansen JA, Martin PJ, McDonald GB, Nash R, Petersdorf EW, Sanders JE, Schoch G, Stewart P, Storb R, Sullivan KM, Thomas ED, Witherspoon RP, Appelbaum FR, Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation, Blood, 1997, 893055-3060. 5. 5）Kim SW, Mori SI, Tanosaki R, Fukuda T, Kami M, Sakamaki H, Yamashita T, Kodera Y, Terakura S, Taniguchi S, Miyakoshi S, Usui N, Yano S, Kawano Y, Nagatoshi Y, Harada M, Morishima Y, Okamoto S, Saito AM, Ohashi Y, Ueda R, Takaue Y, Busulfex (i.v.BU) and CY regimen before SCT: Japanesetargeted phaseⅡ pharmacokinetics combined study, Bone Marrow Transplant, 2009, 43, 611-617.
|
|